CEACAM5 and Merkel cell skin cancer: Numerous molecular markers and prognostic indicators such as carcinoembryonic antigen (CEA), RAS, BRAF mutation, tumor location, and microsatellite instability (MSI) can be used to determine metastatic colon cancer (mCC) prognosis.